Electra announces a major milestone with the successful validation of its EVE‑Ai™ Adaptive Controls platform, enabling ...

BMS technology is indefatigably becoming the cornerstone in today's energy-driven world, considering that efficiency, safety, and reliability are touted above all in many sectors dependent on energy ...

The platform is designed to bring drug prices down in the U.S. to the lowest prices paid in other countries.

A new standard of data center design is emerging, and for the leaders tasked with building the infrastructure of tomorrow, ...

The White House is expected to launch its new prescription drug platform Thursday evening, showcasing the "most favored ...

The United States and India moved closer to a trade pact on Friday, releasing an interim framework that would lower tariffs, ...

Acturis Canada has secured a key endorsement from the Center for Study of Insurance Operations (CSIO), achieving API Security ...

The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

The US MFN healthcare policy aims to cap US prescription drug prices at the lowest price paid in other developed countries.